NCT03200847 2024-10-01Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced MelanomaUniversity of Colorado, DenverPhase 1/2 Completed26 enrolled 13 charts
NCT02842827 2023-07-11IMG-7289-CTP-101Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)Phase 1/2 Completed45 enrolled 41 charts